Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,374 GBX | +0.45% | +2.18% | +16.81% |
02:05pm | ASTRAZENECA : Buy rating from JP Morgan | ZD |
05-13 | AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.81% | 240B | |
+29.98% | 682B | |
+30.88% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+9.85% | 209B | |
-8.43% | 203B | |
+7.09% | 165B | |
-1.22% | 161B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- Stifel Reduces AstraZeneca PT, Keeps Buy Rating